← FDA Drug Approvals (Drugs@FDA)
OCREVUS
BLA · Biologics License Application · Sponsor: GENENTECH INC · Approved 2017-03-28
Drug application
- FDA Application #
BLA761053
- Application type
- Biologics License Application
- Brand name
- OCREVUS
- Generic name
- OCRELIZUMAB
- Active ingredients
- OCRELIZUMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GENENTECH INC
- Manufacturer
- Genentech, Inc.
- First approval
- 2017-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown